Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antenatal Breastmilk Expression in Pregnant Women at High Risk of Preterm Birth
Sponsor: Odense University Hospital
Summary
In this randomized controlled study, the investigators aim to examine if antenatal breastmilk expression (aBME) from week 28 in high-risk pregnancies is a safe and effective method to ensure early access to mother's own milk. In addition, this study will analyze and compare colostrum from pregnancy with colostrum after birth, investigates women's confidence in breastfeeding and breastfeeding establishment as well as measures oxytocin levels during aBME and active labour with no aBME.
Official title: EXPRESSMOM2 in Pregnant Women at High Risk of Preterm Birth. Aspects of Antenatal Breastmilk Expression and Safety From Gestational Week 28-34 and Potential Nutritional Benefits for the Newborn Infant.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2026-09
Completion Date
2029-07
Last Updated
2025-09-24
Healthy Volunteers
No
Interventions
Handstimulation of breast
Hand stimulation of the breast